Search Press releases

Press releases teaser image
18 Sep 2025

UCB announces successful first-in-patient trial for galvokimig in moderate-to-severe atopic dermatitis at EADV

Read More
Press releases teaser image
17 Sep 2025

BIMZELX[®]▼(bimekizumab) new three-year data in hidradenitis suppurativa at EADV showed sustained disease control across the most stringent clinical endpoints

Read More
Press releases teaser image
17 Sep 2025

BIMZELX[®][▼] (bimekizumab) data in moderate-to-severe plaque psoriasis at EADV showed four-year sustained remission, and potential to reduce psoriatic arthritis progression risk

Read More
Press releases teaser image
29 Aug 2025

UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress

Read More
Press releases teaser image
12 Aug 2025

Transparency notification FMR LLC

Read More
Press releases teaser image
31 Jul 2025

From Differentiated Innovation to Outstanding Delivery - A Strong First Half Performance

Read More

Stay up-to-date on the latest news and information from UCB

Subscribe